RxDoctor Payments Data

Charles Leithead, MD

Vascular Surgery · Gretna, LANPI 1215299961

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (51.3%), travel and lodging and education — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Medtronic at 48.4% of the total. Reporting peaked in 2023 at $12,178 and has fallen 90.0% since, to $1,224 in 2025.

$23,440in general payments, 2019–2025

Across 226 payments — averaging $103.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$11K
  • W. L. Gore & Associates, Inc.$5K
  • Abbott$2K
  • Surmodics, Inc.$1K
  • Cook Medical LLC$809
  • Imperative Care, Inc$667
  • plus $3K from 25 others

What the payments were for

  • Travel & lodging$11,34348%
  • Food & beverage$12,03651%
  • Education$610%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,440 in reported general payments places this provider in the 80th percentile of 65 vascular surgery providers in Louisiana.

See all vascular surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$71,205
Medicare patients
234
Services billed
652

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban99$72,572
XareltoRivaroxaban19$10,484
Cilostazol151$3,312
Pentoxifylline101$2,555
ClopidogrelClopidogrel Bisulfate138$540
Prasugrel Hcl12$246
Atorvastatin Calcium16$140
Meloxicam80$106
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen15$89
Alprazolam78$75

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Gretna

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →